Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution

Molecular Biology and Evolution

Volumn 31, Issue 9, 2014, Pages 2387-2401

  Oz, Tugce ^a   Guvenek, Aysegul ^a   Yildiz, Sadik ^a   Karaboga, Enes ^a   Tamer, Yusuf Talha ^a   Mumcuyan, Nirva ^a   Ozan, Vedat Burak ^a   Senturk, Gizem Hazal ^a   Cokol, Murat ^a   Yeh, Pamela ^b   Toprak, Erdal ^a,c  

^a SABANCI UNIVERSITY   (Turkey)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antibiotic resistance; Antibiotic susceptibility; Cross resistance; Evolution; Genotyping; Whole genome sequencing

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; KANAMYCIN; LOMEFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN; SPECTINOMYCIN; SPIRAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFAMONOMETHOXINE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; ABC TRANSPORTER; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; POTASSIUM CHANNEL; TRKH PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; CROSS RESISTANCE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; POINT MUTATION; PROMOTER REGION; SELECTION STRENGTH; STRENGTH; DNA SEQUENCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC SELECTION; GENETICS; MULTIDRUG RESISTANCE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, BACTERIAL; POINT MUTATION; POTASSIUM CHANNELS; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84906751681     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msu191     Document Type: Article

References (47)

1. Alekshun MN, Levy SB. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128:1037-1050.
2. Baba T, Ara T, HasegawaM, Takai Y, Okumura Y, BabaM, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2: 2006.0008.
3. Barrick JE, Yu DS, Yoon SH, Jeong H, Oh TK, Schneider D, Lenski RE, Kim JF. 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243-1247.
4. Bilgin N, Richter AA, Ehrenberg M, Dahlberg AE, Kurland CG. 1990. Ribosomal RNA and protein mutants resistant to spectinomycin. EMBO J. 9:735-739.
5. Bollenbach T, Quan S, Chait R, Kishony R. 2009. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139:707-718.
6. Cao Y, Jin X, Huang H, Derebe MG, Levin EJ, Kabaleeswaran V, Pan Y, Punta M, Love J, Weng J, et al. 2011. Crystal structure of a potassium ion transporter, TrkH. Nature 471:336-340.
7. Chait R, Craney A, Kishony R. 2007. Antibiotic interactions that select against resistance. Nature 446:668-671.
8. Chao L. 1986. Using negative cross-resistance to reduce levels of antibiotic resistance in bacterial populations. In: Levy S, Novick R, editors. Banbury report 24: antibiotic resistance genes: ecology, transfer, and expression. New York: Cold Spring Harbor Laboratory.
9. Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, Suzuki Y, Nergiz ME, Costanzo M, Baryshnikova A, Giaever G, et al. 2011. Systematic exploration of synergistic drug pairs. Mol Syst Biol. 7:544.
10. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-MaedaM, Galagan J, Niemann S, Gagneux S. 2012. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet. 44:106-110.
11. Conrad TM, Joyce AR, Applebee MK, Barrett CL, Xie B, Gao Y, Palsson BO. 2009. Whole-genome resequencing of Escherichia coli K-12 MG1655 undergoing short-term laboratory evolution in lactate minimal media reveals flexible selection of adaptive mutations. Genome Biol. 10:R118.
12. Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 74:417-433.
13. Dragosits M, Mozhayskiy V, Quinones-Soto S, Park J, Tagkopoulos I. 2013. Evolutionary potential, cross-stress behavior and the genetic basis of acquired stress resistance in Escherichia coli. Mol Syst Biol. 9: 643.
14. Flensburg J, Skold O. 1987. Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim. Eur J Biochem. 162:473-476.
15. Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, Uplekar S, Boy-Röttger S, Altmann KH, Cole ST. 2012. Towards a new tuberculosis drug: pyridomycin-nature's isoniazid. EMBO Mol Med. 4: 1032-1042.
16. Hegreness M, Kishony R. 2007. Analysis of genetic systems using experimental evolution and whole-genome sequencing. Genome Biol. 8: 201.
17. Heisig P, Schedletzky H, Falkenstein-Paul H. 1993. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 37:696-701.
18. Imamovic L, Sommer MO. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. 5:204ra132.
19. Jaffe A, Chabbert YA, Derlot E. 1983. Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants. Antimicrob Agents Chemother. 23:622-625.
20. Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martínez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, et al. 2013. EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res. 41:D605-D612.
21. Kohanski MA, DePristo MA, Collins JJ. 2010. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 37:311-320.
22. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 8:423-435.
23. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods. 9:357-359.
24. Lazar V, Pal Singh G, Spohn R, Nagy I, Horváth B, Hrtyan M, Busa-Fekete R, Bogos B, Méhi O, Csörgo B, et al. 2013. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol. 9:700.
25. Lee HH, Molla MN, Cantor CR, Collins JJ. 2010. Bacterial charity work leads to population-wide resistance. Nature 467:82-85.
26. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 10:S122-S129.
27. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25:2078-2079.
28. Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, Davis MR Jr, Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, et al. 2011. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet. 43:1275-1280.
29. Lipsitch M, Bergstrom CT, Levin BR. 2000. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A. 97:1938-1943.
30. Lozovsky ER, Chookajorn T, Brown KM, Imwong M, Shaw PJ, Kamchonwongpaisan S, Neafsey DE, Weinreich DM, Hartl DL. 2009. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci U S A. 106:12025-12030.
31. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martinez- Solano L, Sanchez MB. 2009. A global view of antibiotic resistance. FEMS Microbiol Rev. 33:44-65.
32. Michel JB, Yeh PJ, Chait R, Moellering RC Jr, Kishony R. 2008. Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A. 105:14918:14923.
33. Nichols RJ, Sen S, Choo YJ, Beltrao P, Zietek M, Chaba R, Lee S, Kazmierczak KM, Lee KJ, Wong A, et al. 2011. Phenotypic landscape of a bacterial cell. Cell 144:143-156.
34. Norstrom T, Lannergard J, Hughes D. 2007. Genetic and phenotypic identification of fusidic acid-resistant mutants with the smallcolony- variant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother. 51:4438-4446.
35. Ohmae E, Sasaki Y, Gekko K. 2001. Effects of five-tryptophan mutations on structure, stability and function of Escherichia coli dihydrofolate reductase. J Biochem. 130:439-447.
36. Okusu H, Ma D, Nikaido H. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J Bacteriol. 178: 306-308.
37. Palmer AC, Kishony R. 2013. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat Rev Genet. 14:243-248.
38. Ruiz J. 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 51:1109-1117.
39. Szybalski W, Bryson V. 1952. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol. 64:489-499.
40. Taubes G. 2008. The bacteria fight back. Science 321:356-361.
41. Toprak E, Veres A, Michel JB, Chait R, Hartl DL, Kishony R. 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet. 44:101-105.
42. Torella JP, Chait R, Kishony R. 2010. Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol. 6:e1000796.
43. Watson M, Liu JW, Ollis D. 2007. Directed evolution of trimethoprim resistance in Escherichia coli. FEBS J. 274:2661-2671.
44. Weinreich DM, Delaney NF, Depristo MA, Hartl DL. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114.
45. Yeh P, Tschumi AI, Kishony R. 2006. Functional classification of drugs by properties of their pairwise interactions. Nat Genet. 38:489-494.
46. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R. 2009. Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol. 7: 460-466.
47. YonaAH, ManorYS, HerbstRH, RomanoGH, MitchellA, KupiecM, Pilpel Y, Dahan O. 2012. Chromosomal duplication is a transient evolutionary solution to stress. Proc Natl Acad Sci U S A. 109: 21010-21015.